@article{JGO3188,
author = {Anil Kumar Dhull and Pooja Gogia and Rajeev Atri and Rakesh Dhankhar and Vivek Kaushal and Sunita Singh and Rajeev Sen and Manoj Pal and Amit Lathwal},
title = {Exploring signet-ring cells in pregnant female},
journal = {Journal of Gastrointestinal Oncology},
volume = {6},
number = {2},
year = {2014},
keywords = {},
abstract = {Introduction: Primary signet-ring cell carcinoma (SRCC) of the colon and rectum are rare form, which present at an advanced stage and have poor prognosis. Different treatment policies of SRCC during different gestational age of pregnancy are explored from the literature.
Case study: A 26-year-old young pregnant female with 10-week gestation presented with constipation and blood in stools and on per rectal examination a tender circumferential stricture was present 2 cm above the anal verge. Magnetic resonant imaging (MRI) pelvis of the patient revealed rectal thickening, the biopsy of which revealed characteristic appearance of “linitis plastica” and diagnosed as poorly differentiated adenocarcinoma with signet ring morphology with wide spread positivity for cytokeratin & p53. With this diagnosis, patient underwent medical termination of pregnancy (MTP).
Discussion: SRCC of the colon comprises about only 1% of all cases of colon cancer. When compared with other types of adenocarcinoma, patients with SRCC in the colon are younger and more likely to experience lymph node metastasis. Its incidence in pregnancy is estimated to be less than 0.1%. Certainly, any pregnant patient who reports rectal bleeding or has hemoccult positive stool on examination deserves careful evaluation to rule out cancer. The complex treatment of colorectal cancer in pregnancy is based on the gestational age of the fetus, tumor stage and need for emergent vs. elective management.},
issn = {2219-679X}, url = {https://jgo.amegroups.org/article/view/3188}
}